设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2021 年第 11 期 第 16 卷

血脂异常防治工作是党为人民谋健康的重要体现

The prevention and treatments of dyslipidemia is a major manifestation for the commitment to the people′s health by the Communist Party of China

作者:许晓晗张维君

英文作者:Xu Xiaohan Zhang Weijun

单位:首都医科大学附属北京安贞医院心内科100029

英文单位:Department of Cardiology Beijing Anzhen Hospital Capital Medical University Beijing 100029 China

关键词:

英文关键词:

  • 摘要:
  • 在中国共产党的领导下,人民的生活水平得到了极大的提高,生活方式和饮食结构也发生了一些变化。近年来,动脉粥样硬化性心血管疾病(ASCVD)的相关疾病负担不断增加,并成为危害我国人民生命和健康的首要疾病。以低密度脂蛋白胆固醇升高为特点的血脂异常是ASCVD发生、发展中最主要的危险因素之一。有效控制血脂异常,可显著降低ASCVD的发病及死亡危险,对心脑血管疾病的防控具有重要意义。在庆祝中国共产党成立100周年之际,为加快推进健康中国建设、降低日益加重的ASCVD疾病负担,本文回顾了我国血脂异常的防治进展,并梳理了当今药物治疗的发展现状。旨在引导大家从血脂异常等影响健康因素的前端入手,把“预防为主”的理念落到实处。

  • Under the leadership of the Communist Party of China, the peoples living standards have been greatly improved, and some changes have taken place in their lifestyle and diet. In recent years, atherosclerotic cardiovascular diseases (ASCVD) has increased related burden in China and has become the primary disease endangering the life and health of our people. Dyslipidemia characterized by elevated lowdensity lipoprotein cholesterol, is one of the most important risk factors in the occurrence and development of ASCVD. Effective control of dyslipidemia can significantly reduce the risk of morbidity and mortality of ASCVD, and it is of great significance to the prevention and control of cardiovascular and cerebrovascular diseases. In order to accelerate the promotion of healthy China construction and to reduce the increasing burden of ASCVD, in celebration of 100th anniversary of the founding of the Communist Party of China, this article reviews the progress of the prevention and treatment of dyslipidemia in China and organizes the current development status of drug therapy. We hope to suggest people starting from the frontend of factors affecting health such as dyslipidemia, and to implement the concept of "prevention first" into practice.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭